Despite a common perception that ART leads to moredrug discontinuations in HIV/HCV co-infected patients, especially forcertain compounds, as compared to HIV mono-infected, it remainsunclear whether co-infection leads to higher frequency of treatmentchanges for a given time in care.
Are HIV/HCV co-infected patients more likely to experience multiple lines of ART than HIV mono-infected patients? Results from the ICONA Foundation Study
G. Nunnari;
2016-01-01
Abstract
Despite a common perception that ART leads to moredrug discontinuations in HIV/HCV co-infected patients, especially forcertain compounds, as compared to HIV mono-infected, it remainsunclear whether co-infection leads to higher frequency of treatmentchanges for a given time in care.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
